Top 30 Medical Angel Investors in France in May 2026
Top 30 Medical Angel Investors in France in May 2026
| Investor | Medical France investments |
|---|---|
| Bernard Majoie | 3 |
| André-Jacques Auberton-Hervé | 2 |
| Pierre Kosciusko-Morizet | 2 |
| Nicolas Douay | 2 |
| Guillaume Richard | 2 |
| Bertrand Jelensperger | 2 |
| Nicolas Dessaigne | 2 |
| Daniel Caille | 2 |
| André-Jacques Auberton-Hervé | 2 |
| Bernard Chauvin | 1 |
| Charles-Edouard Bouee | 1 |
| Rémi Gaston- Dreyfus | 1 |
| Flavien Kulawik | 1 |
| Marie Outtier | 1 |
| Geoffrey Duyk | 1 |
| Alain Tingaud | 1 |
| Giorgio Anania | 1 |
| Pierre Olivier Goineau | 1 |
| Yann Fleureau | 1 |
| Pierre Krings | 1 |
| Dominique Vidal | 1 |
| Philippe du Mesnil | 1 |
| Olivier Occelli | 1 |
| Antoine Freysz | 1 |
| Sebastien Gallice | 1 |
| Sacha Loiseau | 1 |
| Victor Douce | 1 |
| Guillaume Amblard | 1 |
| Jean-Paul Kress | 1 |
| Jeanne Kehren | 1 |
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!
Bernard Majoie - President @ Fournier-Majoie
Show more...Investment focus
- Biotechnology, Medical, Health Care
- Seed, Pre-Seed, Series A
- France, Belgium
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cut™ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.
Show more...Investment focus
- Medical, Biotechnology
- Seed, Series A
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Pierre Kosciusko-Morizet is an Internet entrepreneur, founder and former CEO of French e-commerce pioneer PriceMinister. After he sold Priceminister to Japanese internet giant Rakuten in 2010 for $350m, he became Rakuten Europe COO. He left Rakuten in 2014 so as to concentrate on his investments and new project.Pierre Kosciusko-Morizet is agraduate of the famous HEC Paris business school, where he studied entrepreneurship. He launched his first company, Visualis SA (a consultancy for the distribution sector), while still studying at HEC, with a €10,000 student loan. After graduating from HEC, Kosciusko-Morizet moved to the United States and became a manager in the marketing department of Finance Capital One, an internet-based credit card company. There he managed a team of 60 analysts, and specialised in the online credit and banking market.It was there that Kosciusko-Morizet saw a gap in the market. While websites existed in the United States linking buyers and sellers online, there was no equivalent site in France. He resigned from Finance Capital One and returned to France two weeks later to work on what would become PriceMinister with Pierre Krings, Olivier Mathiot, Nathalie Maurin and Justin Ziegler. In 2001 Priceminister launched and has grown into one of the largest and most successful e-commerce companies in France, currently employing around 200 passionate and dedicated staff.Pierre Kosciusko-Morizet is a former President of the ACSEL (Association of the Digital Economy) and of the ASIC (Association of Internet Community Services), and Chairman and main investor of the Strategic Committee of ISAI, the “French internet entrepreneurs fund”, that raised over $100m. In 2010 Kosciusko-Morizet published an autobiographical book which details the story of PriceMinister.
Show more...Investment focus
- Retail, Internet, E-Commerce
- Seed, Series A, Funding Round
- France, Israel
Portfolio highlights
- youzd — youzd is an e-commerce platform for second-hand furniture, electronics, and decoration products.
- PowerZ — Tailored for kids ages 6 and up - learn Math, English, Geography, History, and Music in a universe that adapts to your level!
- Tracktor — Tracktor is an platform that enables construction companies to rent and purchase construction equipment efficiently.
Previously cofounder @ Keldoc - currently early stage investor @ Better Angle
Show more...Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Pre-Seed, Series A
- France, United States, United Kingdom
Portfolio highlights
- Samp — Whatever the scale, age, or number of facilities, Shared Reality helps industrial operators accelerate their digital twin programs in an affordable and accessible way.
- Ambler — Ambler is a startup founded in 2018 by experts in digital and so-called "marketplace" models 100% French, the company enjoys the support of public authorities (Wilco-ex Scientipôle) and the support of prestigious private investors , including Partech, Idinvest Partners, Kima Ventures.The startup is developing technologies to help matchthe supply and demand of medical transports. It aggregates, thanks to win-win partnerships, a considerable fleet of vehicles and offers unparalleled deliverability for contractors. Ambler is the only solution capable, nationwide, of absorbing the constant growth of health transport flows induced by demographic and regulatory factors (reform of regional hospital groups).
- Lalilo — Sign up and invite parents remotely for home access to phonics and reading lessons.
Guillaume Richard is the Founder, Chairman & CEO at Oui Care.He attended EDHEC Business School.
Show more...Investment focus
- Medical, Software, Health Care
- Pre-Seed, Series A
- France
Portfolio highlights
- HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
Bertrand Jelensperger is the Co-Founder and Advisory Board at TheFork.
Show more...Investment focus
- Apps, Software, E-Commerce
- Seed, Series A, Angel
- France, Spain, Belgium
Portfolio highlights
- Malou — Malou offers food marketing and digital marketing solutions for restaurants. The company also offers content management, restaurant marketing, reputation management, presence management, and SEO solutions.
- Kiliba — 100% automated emailing platform: design of html templates in your colours, sending of personalised emails, marketing automation workflows, enriched CRM
- Neptune Elements — Neptune Elements offerFrench seaweed of controlled origin, with exceptional taste and culture.
Nicolas is a firm believer of “culture-first” companies and am focused on building just that at Algolia where team empowerment is how they accomplish their goals. Prior to co-founding Algolia with Julien, he spent over 12 years working on information retrieval at Exalead and Thales.At Algolia they believe every website and app deserves greatsearch! they offer a hosted Search API that helps developers deliver an instant and relevant search experience. We’ve seen that search is a great touch point to optimize – they regularly see double digit increases in engagement on sites when they improve their search UX.When they founded Algolia in 2012 it was originally going to be a local SDK for mobile app search. They changed direction and realized that they needed to offer search as a hosted SaaS service, but it was those early mobile optimizations that gave us their unique advantage. They are one of the few search solutions that has been developed from scratch, and they never would have gone that direction if they hadn’t originally been focused on mobile search.His focus has been first and foremost on making Algolia a great place to work. They have a unique culture here that values ownership as its pillar. They want to create a company where every team member takes initiative, gets out of their comfort zone, is empowered to make decisions; in short: be free to be their best.He is recently spoken at SaaStock on the challenges of running a company based in both Paris and San Francisco. His priority lately has been on scaling their growth and ramping up their team size.
Show more...Investment focus
- Software, Artificial Intelligence, SaaS
- Pre-Seed, Seed, Series A
- United States, France, Germany
Portfolio highlights
- Decima2 — Stop wasting money on Google Ads that don't convert. Decima2 finds what actually works, tests new approaches, and scales your winners.
- Rerun — Iterate faster on robotics learning with unified infrastructure. Ingest, visualize, annotate, query, and transform - from collection to training.
- Twelve Labs — Twelve Labs helps developers make programs that can see, listen, and understand the world as we do by giving them the most powerful video search API
Daniel Caille
Show more...Investment focus
- Elderly, Medical, Software
- Series A, Pre-Seed, Funding Round
- France
Portfolio highlights
- HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
- Medylink —
- CetteFamille — CetteFamille is an economical alternative to retirement homes in France. It is a French network of professional and accredited families to welcome the elderly.CetteFamille is a warm, economical and tailor-made alternative to the retirement home. CetteFamille is a site of connection and a company of services to the person allowing seniors to finda trained and selected family close to home. CetteFamille offers seniors and their families an offer of contact and a follow-up service to carry out all the administrative procedures.On www.cettefamille.com, caregivers of seniors can register to meet a family available nearby. The teams at CetteFamille are responsible for contacting them to study the request and ensure a meeting with the family most appropriate to meet his needs.
Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cut™ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.
Show more...Investment focus
- Medical, Biotechnology
- Seed, Series A
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Bernard Chauvin, a renowned authority in the field of ophthalmology, sits on the company's Board of Directors.March 12, 2013 – EyeTechCare SA, has secured a third round of funding amounting to EUR 10 million. Bernard Chauvin, a private investor, has taken an equity stake in the company alongside two of the existing investors which alsocontributed to this round of funding: the capital investment company Omnes Capital (formerly Crédit Agricole Private Equity) and the Lyon-based insurer SHAM. Bernard Chauvin is a physician specializing in ophthalmology. He headed the Laboratoires Chauvin for 27 years (until its acquisition by Bausch & Lomb), prior to joining Neurotech, a French biotechnology company where he served as Chief Executive Officer until 2004. Since then, he has taken an active role as a director in the development of a number of pharmaceutical and biotechnology companies.
Show more...Investment focus
- Medical, Health Care, Medical Device
- Series A, Series C
- France
Portfolio highlights
- EyeTechCare — EyeTechCare has developed a new medical device called EyeOP1. This leading edge technology device is the result of several years of joint research with INSERM which has led to the development of a treatment method using High Intensity Focused Ultrasound (HIFU).EyeOP1 is an ultrasound device which offers a non-invasive treatment for refractoryglaucoma. This new method is extremely accurate, simple and only takes one minute.
- Ciliatech — Ciliatech is a medtech company specialized in ophthalmology, develops a new class of implant to address the increasing need to treat glaucoma durably and with very minimal adverse effects.
Charles-Edouard Bouée is the CEO of Roland Berger. He is a seasoned expert in reorganization, post-merger projects and integration programs, as well as performance improvement, and specializes in disruptive innovation, new technologies and digital transformation.Charles-Edouard Bouée joined Roland Berger in 2001 as Senior Partner in the Parisoffice, where he headed the Financial Services and Energy & Utility Competence Centers. He became the Managing Partner of Roland Berger’s China office in 2006 and Head of the Asia Leadership Team in 2009.He then assumed responsibility for France, Belgium, Italy, Spain and Morocco. He has since fulfilled consulting mandates for leading international companies and organizations based in Europe, Asia and elsewhere. Charles-Edouard Bouée was appointed COO in July 2013 and elected CEO of Roland Berger in June 2014.Charles-Edouard Bouée has authored various books on modern management and China, as well as Artificial Intelligence.
Show more...Investment focus
- AgTech, Beauty, Mining
- Pre-Seed, Seed, Angel
- United States, France, Vietnam
Portfolio highlights
- xRapid — xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence. xRapid is a Biotech startup based in Aix en Provence (France), London (Uk), and Las Vegas. xRapid saw its beginnings in a laboratory in Jakarta. Their CTO, Professor David Mendels, recognized that he was able to develop a mobilesolution for malaria diagnosis after attending a conference. Since then he has created xRapid, a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhea.
- PaySika — Un compte, une carte bancaire gratuite
- INTERSTELLAR LAB — autonomous modules for crop cultivation on Earth and life-support in Space
Rémi Gaston- Dreyfus
Show more...Investment focus
- Medical, Biotechnology
- Seed
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Flavien Kulawik
Show more...Investment focus
- Health Care, Artificial Intelligence, SaaS
- Seed, Funding Round, Series A
- France, United Kingdom
Portfolio highlights
- Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
- Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
- Scienta Lab — Accelerate translational breakthroughs in immunology and inflammation with the first predictive model of human immune response. Bridge preclinical to clinical.
Marie is a tech entrepreneur and investor. She co-founded and ran Aiden.ai, a B2B Saas that was acquired by Twitter in 2019. She served as Director of Product at Twitter until November 2022 and left as Twitter was becoming X. She is one of the most active angel investors in Europe with over 25 investments she made in the last three years alone inthe UK, France, the US. 56% of her portfolio has at least one female founder.
Show more...Investment focus
- Health Care, Biofuel, Fitness
- Seed, Pre-Seed
- France, United States, The Netherlands
Portfolio highlights
- omena — Oména is working on a digital handbook to assist women as they transition through menopause.
- Gigi — AI social app
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Dr. Geoffrey Duyk was a member of the Board from May 2006 through May 2011, and re-joined the Board in May 2012. Dr. Duyk is a partner of TPG Growth, LLC, an affiliate of TPG Biotechnology Partners II, L.P.Previously, he served on the board of directors and was President of Research and Development at Exelixis, Inc., a biopharmaceutical companyfocusing on drug discovery, from 1996 to 2003.Prior to Exelixis, Dr. Duyk was Vice President of Genomics and one of the founding scientific staff at Millennium Pharmaceuticals, from 1993 to 1996.Before that, Dr. Duyk was an Assistant Professor at Harvard Medical School in the Department of Genetics and Assistant Investigator of the Howard Hughes Medical Institute.Dr. Duyk currently serves on the boards of directors of several private companies and the non-profit Wesleyan University Board of Trustees. He served on the board of directors of Agria Corporation from August 2007 to May 2009, Cardiovascular Systems, Inc. (formerly Replidyne, Inc.) from 2004 to February 2009, Exelixis, Inc. from 1996 to 2003. Dr. Duyk holds a Bachelor of Arts degree in Biology from Wesleyan University and Doctor of Philosophy and Medicine degrees from Case Western Reserve University.
Show more...Investment focus
- Biotechnology, Medical, Chemical
- Series A, Series B, Series C
- United States, Japan, France
Portfolio highlights
- DNAnexus — The world's most secure & trusted biomedical cloud platform that accelerates clinical and scientific discovery with the potential to improve patient lives.
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
- Aerie Pharmaceuticals — Aerie Pharmaceuticals, a leading ophthalmic pharmaceuticals company conducting R&D of products for treating patients with glaucoma and other eye diseases.
Alain Tingaud is a Founder & CEO at Alain Tingaud Innovations.
Show more...Investment focus
- Software, E-Commerce, Cryptocurrency
- Pre-Seed, Seed
- France, Luxembourg
Portfolio highlights
- Gonuggets — We help digitally native brands to grow their e-commerce revenue on marketplaces such as Amazon and D2C across EMEA.
- MarketLeap — Breaking E-commerce Barriers with Software. MarketLeap is managing all the complexities of selling and growing on marketplaces worldwide.
- Trendex — Mobile App
Giorgio has spent more than 30 years in senior management at high-technology companies, from start-up ventures to international public companies, and has led two successful IPOs. He is chairman of Cube Optics AG and vice president of the executive board at Photonics21.Previously, Giorgio was CEO of Bookham, now Oclaro, which he grew from astart-up into a quarter-billion-dollar NASDAQ-listed public company. He also served as the vice president of sales, finance and business development for Flamel Technologies.Prior to that, he was the founder and general manager of the Miniplex DSL Business Unit at Raychem and strategy consultant at Booz Allen.He has a M.A. degree in physics from Oxford University and a Ph.D. in thermonuclear fusion from Princeton University.
Show more...Investment focus
- Medical, Biotechnology
- Seed
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Pierre Olivier Goineau - President @ Neuronax
Show more...Investment focus
- Medical, Biopharma, Health Care
- Funding Round
- France
Portfolio highlights
- Ixaltis — Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik andProfessors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders.IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.
Yann sets the vision and strategic direction for Cardiologs and is the guardian of company culture. He is a frequent speaker at industry conferences and is recognized as a thought leader in the application of AI in healthcare. Yann graduated with a degree in Computer Science and Biology from Ecole Polytechnique Paris (X) and the Silicon ValleyInnovation and Entrepreneurship program at UC Berkeley.He was recently named one of MIT Technology Review's Innovators Under 35 in Europe and BNP Paribas European Innovator of the Year. Yann is passionate about the intersection of new technology & clinical practice and is excited to be building a leading company that will help usher in a new era for healthcare worldwide.
Show more...Investment focus
- Health Care, Medical Device, Artificial Intelligence
- Series A, Series B
- France
Portfolio highlights
- Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
- Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
- Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.
Pierre Krings is the founder of Price Minister.
Show more...Investment focus
- Rental, Retail, Fashion
- Funding Round, Seed, Series A
- France
Portfolio highlights
- Jam — Jam uses AI and process optimization to assist students in their daily lives.
- Tracktor — Tracktor is an platform that enables construction companies to rent and purchase construction equipment efficiently.
- Renovation Man — Renovation Man is a provider of services intended to revolutionize the world of renovation work.
Dominique Vidal is a Venture Partner at Index Ventures.
Show more...Investment focus
- Internet, Software, E-Commerce
- Series A, Seed, Series B
- France, United States, United Kingdom
Portfolio highlights
- Koyeb — Koyeb is a developer-friendly serverless platform to deploy apps globally. No-ops, servers, and infrastructure management.
- OpenReplay — Open-source session replay and product analytics you can self-host for full control over data security and privacy.
- HrFlow.ai — Meet the first AI agents and Foundation models trained on billions of interview outcomes. The Hiring SuperIntelligence predicts your next hires and who's worth meeting, saving managers thousands of hours wasted on false positives.
Philippe du Mesnil, a private investor
Show more...Investment focus
- Medical, Manufacturing, Medical Device
- Funding Round
- France
Portfolio highlights
- Ilasis — Discover Rx, the new femtosecond laser for performing a perfect capsulotomy in cataract surgery. Rx is the new innovation of Helix Surgical.
Olivier started his career in 1998 as a Production and Quality Manager for DeliFrance, managing over 50 employees in three shifts, 7 days a week.In 2001, he became Sales Director for IMDS, a leading hosting and IT solutions provider in Western Europe. In 2007, Olivier founded NaturaBuy, a marketplace dedicated to outdoor sports, hunting andfishing, addressing a €2.5 billion market in France. NaturaBuy is now the leading marketplace of its sector, powering tens of thousands of transactions each month and €60 million in annual Transaction Volume.Olivier has backed some the most successful Kerala startups from their creation, such as Doctolib, Malt, admo.tv and Privateaser.Olivier holds a MSc in Engineering.Past and current Boards: Kerala Ventures, NaturaBuy (as CEO)
Show more...Investment focus
- Medical, Hospital, Health Care
- Seed
- France
Portfolio highlights
- Doctolib — Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France.
After launching his first venture in 2000 (exited in 2002), Antoine joined the Travelocity / Lastminute group as Sales Director and then becoming COO. At that time, he directly managed 200 employees, including 50 salespeople.In 2009, he cofounded the “Startup Studio” Otium with Pierre-Edouard Sterin, Smartbox’s founder. Antoine built thefounding team, hiring Stanislas Niox-Château and Philippe de Chanville (5 years later, Stan will found Doctolib and Philippe ManoMano). As Otium CEO, Antoine conducted the acquisition of LaFourchette in 2009, led Lafourchette’s Board for 6 years (the startup grew from 3 to 250 salaries across 4 markets) and conducted the exit process to TripAdvisor in May 2014.Antoine cofounded a total of 6 “Otium” startups, among others Balinea, the leading platform for beauty institute bookings, and Weekendesk, an OTA for weekends generating above €100 million in Transaction Volume in 5 countries.Antoine graduated from HEC Paris.
Show more...Investment focus
- SaaS, Internet, Software
- Seed, Series A, Pre-Seed
- France
Portfolio highlights
- RockFi — RockFi is a private management company offering wealth management services.
- Doctolib — Doctolib is an online booking platform and management software provider for doctors in Europe working with 65 000 health practitioners, present in 1 300 health facilities. 25 million patients visit Doctolib website and mobile app every month.For doctors, Doctolib is a full-range service to improve bookings management, reduce no-show and bring newpatients to your office. For patients, Doctolib is a free online service to find a nearby health practitioner and book doctor or dentist appointments 24/24 and 7/7 within a few clicks.Founded in 2013, Doctolib is based out of Paris, France.
- Delos — Delos is a generative AI platform for organizational and business development for companies.
Sebastien Gallice
Show more...Investment focus
- Medical, 3D Printing, Pharmaceutical
- Seed
- France
Portfolio highlights
- MB Therapeutics — MB Therapeutics is a pharmaceutical firm that provides patient-centric solutions for developing and producing tailored medicines.
Sacha Loiseau is based out of Paris, Ile-de-France, and is the Founder, CEO, and Chairman of the Board at Mauna Kea Technologies. Sacha previously served as a Board Member at Sonio. Sacha Loiseau attended Université de Paris. Sacha Loiseau has received Marius Lavet Prize "engineer and inventor" award.
Show more...Investment focus
- Health Care, Medical Device, Medical
- Series A, Pre-Seed, Series B
- France
Portfolio highlights
- AQEMIA — Aqemia is an in silico drug discovery start-up, whose ambition is to discover rapidly more innovative therapeutic molecules with better chances of success.
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- BrightHeart — BrightHeart develops an AI-based platform for fetal ultrasound analysis to improve detection of congenital heart defects.
Victor Douce
Show more...Investment focus
- Health Care, FinTech, Medical
- Series C, Funding Round, Pre-Seed
- United States, France, Germany
Portfolio highlights
- Magnisense — Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires
- The EVERY Company — The EVERY Company, Formerly Clara Foods making Protein | Vegan Egg Protein Ingredients.
- Terran Biosciences — Terran Biosciences is developing therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.
Guillaume Amblard
Show more...Investment focus
- Software, Banking, FinTech
- Seed, Funding Round, Series A
- France, United Kingdom, Tunisia
Portfolio highlights
- Uptale — Uptale provides an enterprise solution that enhances employee learning through immersive experiences in 360° and virtual reality. The platform allows organizations to create, share, and analyze training modules without requiring technical expertise.
- Wattnow — Wattnow is a real-time monitoring solution that provides a breakdown of energy spending to identify wasteful trends.
- Thunder Code — Transform your QA process with Thunder Code's AI-powered test automation platform. Create, manage, and run automated tests without coding - perfect for QA teams seeking efficiency, reliability, and seamless integration.
Jean-Paul Kress
Show more...Investment focus
- Medical, Biotechnology
- Seed
- France
Portfolio highlights
- LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Jeanne Kehren is the SVP Digital & Commercial Innovation & CIO at Bayer. She attended Alfort National Veterinary School - EnvA.
Show more...Investment focus
- Medical, Health Care, Neuroscience
- Seed
- France
Portfolio highlights
- Clarity — Our brain computer interface uses the power of light and sound to treat neurodegenerative diseases, without the need for drugs or implants.
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!
